Faculty
Eugene Lin
Contact
Calcimimetic Prescriptions in Fee-for-Service Medicare Beneficiaries Undergoing Dialysis JAMA Health Forum. 2025 Apr 04; 6(4):e250452. . View in PubMed
Care Continuity, Nephrologists' Dialysis Facility Preferences, and Outcomes JAMA Health Forum. 2025 Apr 04; 6(4):e250423. . View in PubMed
Association of Kidney Function With Inpatient Mortality and Morbidity After Cardiac Surgery Ann Thorac Surg Short Rep. 2024 Dec; 2(4):877-883. . View in PubMed
Examining chronic kidney disease screening frequency among diabetics: a POMDP approach Health Care Manag Sci. 2024 Sep; 27(3):391-414. . View in PubMed
Cataract Surgery in the Medicare Merit-Based Incentive Payment System: Episode-Based Cost Measure Development and Evaluation Ophthalmol Sci. 2023 Dec; 3(4):100315. . View in PubMed
Disparities in the Timing of Preoperative Hemodialysis Among Patients With End-Stage Kidney Disease JAMA Netw Open. 2023 07 03; 6(7):e2326326. . View in PubMed
On the path to individualizing care with incremental-start hemodialysis J Nephrol. 2023 Jul; 36(6):1505-1508. . View in PubMed
Nephrology and the US News and World Report Hospital-Based Specialty Rankings Kidney Med. 2023 Apr; 5(4):100620. . View in PubMed
Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With End-stage Kidney Disease-Reply JAMA. 2023 03 21; 329(11):939-940. . View in PubMed
J Am Soc Nephrol. 2023 02 01; 34(2):193-194. . View in PubMed
The New Kidney-Focused Companies: A Privatized Approach to Value-Based Care and Addressing Social Determinants of Health J Am Soc Nephrol. 2023 01 01; 34(1):17-20. . View in PubMed
APOL1 Genotype, Proteinuria, and the Risk of Kidney Failure: A Secondary Analysis of the AASK (African American Study of Kidney Disease and Hypertension) and CRIC (Chronic Renal Insufficiency Cohort) Studies Kidney Med. 2022 Dec; 4(12):100563. . View in PubMed
Association Between Nephrologist Ownership of Dialysis Facilities and Clinical Outcomes JAMA Intern Med. 2022 12 01; 182(12):1267-1276. . View in PubMed
A Blueprint for Assessing Affordability of SGLT2 Inhibitors in the United States: The Cost-Effectiveness of Dapagliflozin in Three European Countries Clin J Am Soc Nephrol. 2022 12; 17(12):1707-1709. . View in PubMed
Racial disparities and standard treatment in locally advanced rectal cancer: a National Cancer Database study J Gastrointest Oncol. 2022 Dec; 13(6):2922-2937. . View in PubMed
Association Between Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With End-stage Kidney Disease JAMA. 2022 11 08; 328(18):1837-1848. . View in PubMed
J Am Soc Nephrol. 2022 11 01; 33(11):1963-1965. . View in PubMed
Author Correction: Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions Nat Rev Nephrol. 2022 Nov; 18(11):738. . View in PubMed
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions Nat Rev Nephrol. 2022 11; 18(11):724-737. . View in PubMed
Medicare Advantage Plans Pay Large Markups To Consolidated Dialysis Organizations Health Aff (Millwood). 2022 08; 41(8):1107-1116. . View in PubMed
Patient Frailty and Functional Use of Hemodialysis Vascular Access: A Retrospective Study of the US Renal Data System Am J Kidney Dis. 2022 07; 80(1):30-45. . View in PubMed
Time to Invest in the Future: Assessing the Cost-Effectiveness of Empagliflozin in Diabetic Kidney Disease Am J Kidney Dis. 2022 06; 79(6):780-782. . View in PubMed
Health Policy Trends in Kidney Disease Adv Chronic Kidney Dis. 2022 01; 29(1):3-4. . View in PubMed
Challenging Assumptions of Outcomes and Costs Comparing Peritoneal and Hemodialysis Value Health. 2021 11; 24(11):1592-1602. . View in PubMed
Acral lentiginous melanoma-Population, treatment, and survival using the NCDB from 2004 to 2015 Pigment Cell Melanoma Res. 2021 11; 34(6):1049-1061. . View in PubMed
Payment for Dialysis Services in the Individual Market JAMA Intern Med. 2021 05 01; 181(5):698-699. . View in PubMed
Development of the Elective Outpatient Percutaneous Coronary Intervention Episode-Based Cost Measure Circ Cardiovasc Qual Outcomes. 2021 03; 14(3):e006461. . View in PubMed
The Cost of Transferring Dialysis Care From the Employer-Based Market to Medicare JAMA Netw Open. 2021 03 01; 4(3):e212113. . View in PubMed
Racial disparities in receipt of standard chemoradiation in anal squamous cell carcinoma, an analysis of the National Cancer Database Cancer Med. 2021 01; 10(2):575-585. . View in PubMed
What the Comprehensive ESRD Care Program Tells Us About the Advancing American Kidney Health Initiative Am J Kidney Dis. 2020 12; 76(6):893-895. . View in PubMed
Hospitalizations among adults with chronic kidney disease in the United States: A cohort study PLoS Med. 2020 12; 17(12):e1003470. . View in PubMed
The "Advancing American Kidney Health" Executive Order: Challenges and Opportunities for the Large Dialysis Organizations Am J Kidney Dis. 2020 11; 76(5):731-734. . View in PubMed
Payer Mix Among Patients Receiving Dialysis JAMA. 2020 09 01; 324(9):900-901. . View in PubMed
Policy and Pandemic: The Changing Practice of Nephrology During the Coronavirus Disease-2019 Outbreak Adv Chronic Kidney Dis. 2020 09; 27(5):390-396. . View in PubMed
Early Delays in Insurance Coverage and Long-term Use of Home-based Peritoneal Dialysis Med Care. 2020 07; 58(7):632-642. . View in PubMed
Conflicts of interest in dialysis: A barrier to policy reforms Semin Dial. 2020 01; 33(1):83-89. . View in PubMed
Competing with a pandemic: Trends in research design in a time of Covid-19 PLoS One. 2020; 15(9):e0238831. . View in PubMed
Four years into MACRA: What has changed? Semin Dial. 2020 01; 33(1):26-34.. View in PubMed
The dialysis care-policy issue: Guest Editors' introductory remarks Semin Dial. 2020 01; 33(1):4. . View in PubMed
Calcimimetics and Bundled Reimbursement Am J Kidney Dis. 2019 03; 73(3):385-390. . View in PubMed
Prior Hospitalization Burden and the Relatedness of 30-Day Readmissions in Patients Receiving Hemodialysis J Am Soc Nephrol. 2019 02; 30(2):323-335. . View in PubMed
Health Insurance in the First 3 Months of Hemodialysis and Early Vascular Access Clin J Am Soc Nephrol. 2018 12 07; 13(12):1866-1875. . View in PubMed
Addressing Financial Disincentives to Improve CKD Care J Am Soc Nephrol. 2018 11; 29(11):2610-2612. . View in PubMed
Palliative Care Disincentives in CKD: Changing Policy to Improve CKD Care Am J Kidney Dis. 2018 06; 71(6):866-873. . View in PubMed
Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study PLoS Med. 2018 03; 15(3):e1002532. . View in PubMed
Development of a Radiation Oncology Resident Continuity Clinic to Improve Clinical Competency and Patient Compliance Int J Radiat Oncol Biol Phys. 2018 03 01; 100(3):551-555. . View in PubMed
Home Dialysis in the Prospective Payment System Era J Am Soc Nephrol. 2017 Oct; 28(10):2993-3004. . View in PubMed
The Medicare Access and CHIP Reauthorization Act: Implications for Nephrology J Am Soc Nephrol. 2017 Sep; 28(9):2590-2596. . View in PubMed
Re-evaluation of re-hospitalization and rehabilitation in renal research Hemodial Int. 2017 07; 21(3):422-429. . View in PubMed
Early rehospitalization after kidney transplantation: assessing preventability and prognosis Am J Transplant. 2013 Dec; 13(12):3164-72. . View in PubMed
Overtreatment of enterococcal bacteriuria Arch Intern Med. 2012 Jan 09; 172(1):33-8. . View in PubMed
Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease FASEB J. 2011 May; 25(5):1653-63. . View in PubMed
Bacteria in the treatment of cancer Curr Opin Mol Ther. 2004 Dec; 6(6):629-39. . View in PubMed
Oncolytic viral therapies Cancer Gene Ther. 2004 Oct; 11(10):643-64. . View in PubMed
In addition to his role as an Assistant Professor of Medicine in the Division of Nephrology & Hypertension, he is also a Clinical and Resident Fellow at the Leonard D. Schaeffer Center for Health Policy & Economics.
Dr. Lin is a nationally recognized expert on payment policy and currently serves on the National Kidney Foundation’s Scientific Advisory Board and the American Society of Nephrology’s Transplant Policy Committee. He has previously served on the ASN's Quality and Policy and Advocacy Committees. He has participated as a key stakeholder in multiple Technical Expert Panels for the Centers for Medicare and Medicaid Services.
Dr. Lin completed a postdoctoral fellowship in nephrology at the Stanford School of Medicine and completed his Internal Medicine residency at the Hospital of the University of Pennsylvania.
He is an NIH funded investigator, and his work has been published in leading health policy and medical journals, including JAMA, Health Affairs, and JAMA Internal Medicine.
